相似文献
1
Combination of Irreversible Electroporation and STING Agonist for Effective Cancer Immunotherapy.
Cancers (Basel). 2020 Oct 26;12(11):3123. doi: 10.3390/cancers12113123.
2
Robust and Sustained STING Pathway Activation via Hydrogel-Based In Situ Vaccination for Cancer Immunotherapy.
ACS Nano. 2024 Oct 29;18(43):29439-29456. doi: 10.1021/acsnano.3c12337. Epub 2024 Oct 15.
3
T-cell activation and immune memory enhancement induced by irreversible electroporation in pancreatic cancer.
Clin Transl Med. 2020 Jun;10(2):e39. doi: 10.1002/ctm2.39. Epub 2020 Jun 4.
4
Combination of a STING Agonist and Photothermal Therapy Using Chitosan Hydrogels for Cancer Immunotherapy.
Biomacromolecules. 2023 Jun 12;24(6):2790-2803. doi: 10.1021/acs.biomac.3c00196. Epub 2023 May 1.
5
Combination of Metal-Phenolic Network-Based Immunoactive Nanoparticles and Bipolar Irreversible Electroporation for Effective Cancer Immunotherapy.
Small. 2022 Jun;18(25):e2200316. doi: 10.1002/smll.202200316. Epub 2022 May 16.
6
OX40 agonist combined with irreversible electroporation synergistically eradicates established tumors and drives systemic antitumor immune response in a syngeneic pancreatic cancer model.
Am J Cancer Res. 2021 Jun 15;11(6):2782-2801. eCollection 2021.
7
Manganese-Enriched Zinc Peroxide Functional Nanoparticles for Potentiating Cancer Immunotherapy.
Nano Lett. 2023 Nov 22;23(22):10350-10359. doi: 10.1021/acs.nanolett.3c02941. Epub 2023 Nov 6.
8
Synthetic Immunogenic Cell Death Mediated by Intracellular Delivery of STING Agonist Nanoshells Enhances Anticancer Chemo-immunotherapy.
Nano Lett. 2020 Apr 8;20(4):2246-2256. doi: 10.1021/acs.nanolett.9b04094. Epub 2020 Mar 17.
9
STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade.
J Clin Invest. 2019 Jul 25;129(10):4350-4364. doi: 10.1172/JCI125413.
10
Irreversible Electroporation Combined with Checkpoint Blockade and TLR7 Stimulation Induces Antitumor Immunity in a Murine Pancreatic Cancer Model.
Cancer Immunol Res. 2019 Oct;7(10):1714-1726. doi: 10.1158/2326-6066.CIR-19-0101. Epub 2019 Aug 13.
引用本文的文献
1
Calcium Electrochemotherapy and Challenges in Combined Treatment with Dendritic Cell Vaccination.
Pharmaceutics. 2025 Jun 21;17(7):804. doi: 10.3390/pharmaceutics17070804.
2
Ablation combined with video-assisted thoracic surgery hybrid technique for multiple primary lung cancer.
iScience. 2025 May 20;28(6):112703. doi: 10.1016/j.isci.2025.112703. eCollection 2025 Jun 20.
3
Numerical assessments of geometry, proximity and multi-electrode effects on electroporation in mitochondria and the endoplasmic reticulum to nanosecond electric pulses.
Sci Rep. 2024 Oct 11;14(1):23854. doi: 10.1038/s41598-024-74659-z.
4
Signature identification based on immunogenic cell death-related lncRNAs to predict the prognosis and immune activity of patients with endometrial carcinoma.
Transl Cancer Res. 2024 Jun 30;13(6):2913-2937. doi: 10.21037/tcr-23-2243. Epub 2024 Jun 27.
5
STING pathway as a cancer immunotherapy: Progress and challenges in activating anti-tumor immunity.
Mol Biol Rep. 2024 Apr 5;51(1):487. doi: 10.1007/s11033-024-09418-4.
6
Harnessing innate immune pathways for therapeutic advancement in cancer.
Signal Transduct Target Ther. 2024 Mar 25;9(1):68. doi: 10.1038/s41392-024-01765-9.
7
The effects of irreversible electroporation triggering anti-tumor immunity and the value of its combination with immunotherapy.
J Interv Med. 2023 Aug 7;6(3):107-110. doi: 10.1016/j.jimed.2023.07.005. eCollection 2023 Aug.
8
Lipid nanoparticle-based mRNA delivery systems for cancer immunotherapy.
Nano Converg. 2023 Aug 7;10(1):36. doi: 10.1186/s40580-023-00385-3.
9
Pulsed Electric Fields in Oncology: A Snapshot of Current Clinical Practices and Research Directions from the 4th World Congress of Electroporation.
Cancers (Basel). 2023 Jun 25;15(13):3340. doi: 10.3390/cancers15133340.
10
Combining energy-based focal ablation and immune checkpoint inhibitors: preclinical research and clinical trials.
Front Oncol. 2023 May 1;13:1153066. doi: 10.3389/fonc.2023.1153066. eCollection 2023.
本文引用的文献
1
Synthetic Immunogenic Cell Death Mediated by Intracellular Delivery of STING Agonist Nanoshells Enhances Anticancer Chemo-immunotherapy.
Nano Lett. 2020 Apr 8;20(4):2246-2256. doi: 10.1021/acs.nanolett.9b04094. Epub 2020 Mar 17.
2
An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases.
Nat Commun. 2019 Nov 8;10(1):5108. doi: 10.1038/s41467-019-13094-5.
3
STING: a master regulator in the cancer-immunity cycle.
Mol Cancer. 2019 Nov 4;18(1):152. doi: 10.1186/s12943-019-1087-y.
4
Irreversible electroporation of locally advanced pancreatic cancer transiently alleviates immune suppression and creates a window for antitumor T cell activation.
Oncoimmunology. 2019 Aug 28;8(11):1652532. doi: 10.1080/2162402X.2019.1652532. eCollection 2019.
5
STING signaling is a potential immunotherapeutic target in colorectal cancer.
J Cancer. 2019 Aug 27;10(20):4932-4938. doi: 10.7150/jca.32806. eCollection 2019.
6
Characterization of Ablation Thresholds for 3D-Cultured Patient-Derived Glioma Stem Cells in Response to High-Frequency Irreversible Electroporation.
Research (Wash D C). 2019 Apr 28;2019:8081315. doi: 10.34133/2019/8081315. eCollection 2019.
7
Multifunctional nanoparticles for genetic engineering and bioimaging of natural killer (NK) cell therapeutics.
Biomaterials. 2019 Nov;221:119418. doi: 10.1016/j.biomaterials.2019.119418. Epub 2019 Aug 9.
8
STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade.
J Clin Invest. 2019 Jul 25;129(10):4350-4364. doi: 10.1172/JCI125413.
9
Immunogenic cell death in cancer therapy: Present and emerging inducers.
J Cell Mol Med. 2019 Aug;23(8):4854-4865. doi: 10.1111/jcmm.14356. Epub 2019 Jun 18.
10
Therapeutic Effect of Irreversible Electroporation in Combination with Poly-ICLC Adjuvant in Preclinical Models of Hepatocellular Carcinoma.
J Vasc Interv Radiol. 2019 Jul;30(7):1098-1105. doi: 10.1016/j.jvir.2019.02.023. Epub 2019 May 14.
Zotero 插件
